Spots Global Cancer Trial Database for SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLC
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLC
Official Title: Stereotactic Body Radiation Therapy Compared With Intensity Modulated Radiation Therapy Concurrently With Chemotherapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Study ID: NCT02738723
Conditions
Study Description
Brief Summary: As stereotactic radiotherapy (SBRT) has been widely used in clinical practice at present, the aim of this study is to evaluate the efficacy and safety of stereotactic body radiation therapy compared with intensity modulated radiation therapy (IMRT) concurrently with EP regimen(cisplatin plus etoposide) in treating patients with limited-stage small cell lung cancer
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Daping Hospital, Third Military Medical University, Chongqing, Chongqing, China
Contact Details
Name: Xueqin Yang, PHD
Affiliation: Daping Hospital, Third Military Medical University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
